Education
About Us
Working with TipRanks
Follow Us
William M. Moore Insider Profile
4 Followers
William M. Moore, Director at Iridex, holds 402.00K shares in Iridex (Ticker: IRIX), holds 123.96K shares in Natus Medical (Ticker: NTUS), holds 69.15K shares in Urologix (Ticker: ULGX). Most recently, William M. Moore Bought ― shares of Iridex on Dec 18, 2025 for an estimated value of $2.00K.
Profitable Transactions
18 out of 31 Profitable Transactions
Average Return
+0.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by William M. Moore
William M. Moore's Trading History
Iridex
Dec 18, 2025
Director
Informative Buy
2.00K
$566.82K
Natus Medical
Nov 15, 2017
―
Informative Sell
205.05K
$4.10M
Urologix
Nov 18, 2009
Director
Informative Buy
19.50K
$829.85
List of latest transactions for each holding click on a transaction to see William M. Moore's performance on stock
You May Also Like
William M. Moore insider profile FAQ
What is the percentage of profitable transactions made by William M. Moore?
The percentage of profitable transactions made by William M. Moore is 58%.
What is the average return per transaction made by William M. Moore?
The average return per transaction made by William M. Moore is 0.40%.
What stocks does William M. Moore hold?
William M. Moore holds: IRIX, NTUS, ULGX stocks.
What was William M. Moore’s latest transaction?
William M. Moore latest transaction was an Informative Buy of $2.00K.
What was William M. Moore's most profitable transaction?
William M. Moore’s most profitable transaction was an Informative Buy of IRIX stock on November 19, 2015. The return on the trade was 64.40%.
What is William M. Moore's role in Iridex?
William M. Moore's role in Iridex is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.